We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information about ensuring blood and blood component safety.
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
What blood establishments, blood banks and manufacturers of blood products need to do to ensure the safety and quality of blood and blood products.
The NHSBT / PHE epidemiology unit, and the epidemiology of infections among blood, tissue and organ donors and recipients.
Information and guidance on a range of medical devices for users and patients.
Scientific opinion from the UK Nutrition and Health Claims Committee (UKNHCC) for the substantiation of an Article 14(1)(a) health claim: Morus alba leaf extract and blood glucose levels.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Millions at risk from 'silent killer' as NHS campaign warns there are often 'no clues' when it comes to high blood pressure.
First published during the 2022 to 2024 Sunak Conservative government
Information for parents about glutaric aciduria type 1 (GA1) following a baby’s screening test result.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).